Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
KRP-114V Phase I Trial in Pediatric Overactive Bladder
jRCT2031220314Phase 1Completed
- Sponsor
- Kyorin Pharmaceutical
- Start
- Dec 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, single-blind trial of vibegron in overactive bladder (OAB) (2 arms), sponsored by Kyorin Pharmaceutical. Primary endpoints: Safety endpoints and Pharmacokinetic endpoints. Started Dec 2022; status: completed.
02
Drugs
vibegron
03
Conditions
overactive bladder (OAB)
Beyond the preview
Go deeper on jRCT2031220314.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2031220314.